Published in Int J Nanomedicine on September 16, 2014
Photoacoustic Imaging of Cancer Treatment Response: Early Detection of Therapeutic Effect from Thermosensitive Liposomes. PLoS One (2016) 1.40
Roadmap to Clinical Use of Gold Nanoparticles for Radiation Sensitization. Int J Radiat Oncol Biol Phys (2015) 0.96
Systems biology approaches to adverse drug effects: the example of cardio-oncology. Nat Rev Clin Oncol (2015) 0.85
Towards nanomedicines of the future: Remote magneto-mechanical actuation of nanomedicines by alternating magnetic fields. J Control Release (2015) 0.85
The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo. Int J Nanomedicine (2015) 0.78
Cytotoxicity of gemcitabine-loaded thermosensitive liposomes in pancreatic cancer cell lines. Integr Cancer Sci Ther (2015) 0.77
Pharmacokinetics, Tissue Distribution and Therapeutic Effect of Cationic Thermosensitive Liposomal Doxorubicin Upon Mild Hyperthermia. Pharm Res (2015) 0.76
Biological mechanisms of gold nanoparticle radiosensitization. Cancer Nanotechnol (2017) 0.75
Effects of X-shaped reduction-sensitive amphiphilic block copolymer on drug delivery. Int J Nanomedicine (2015) 0.75
Gold Nanoantenna-Mediated Photothermal Drug Delivery from Thermosensitive Liposomes in Breast Cancer. ACS Omega (2016) 0.75
Focal point determination in magnetic resonance-guided focused ultrasound using tracking coils. Magn Reson Med (2016) 0.75
Soft Interaction in Liposome Nanocarriers for Therapeutic Drug Delivery. Nanomaterials (Basel) (2016) 0.75
In vitro and in vivo antitumor activity of gemcitabine loaded thermosensitive liposomal nanoparticles and mild hyperthermia in pancreatic cancer. Int J Adv Res (Indore) (2015) 0.75
Nanomedicines for dysfunctional macrophage-associated diseases. J Control Release (2017) 0.75
Strategies for improving the intratumoral distribution of liposomal drugs in cancer therapy. Expert Opin Drug Deliv (2016) 0.75
Effective elimination of liver cancer stem-like cells by CD90 antibody targeted thermosensitive magnetoliposomes. Oncotarget (2016) 0.75
Structure and Function of Trypsin-Loaded Fibrinolytic Liposomes. Biomed Res Int (2017) 0.75
Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol (1965) 7.58
Investigation of phase transitions of lipids and lipid mixtures by sensitivity differential scanning calorimetry. Proc Natl Acad Sci U S A (1976) 7.41
The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul (2001) 6.59
The function of sterols in membranes. Biochim Biophys Acta (1976) 5.93
Randomized phase II comparison of dose-intense gemcitabine: thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma. J Clin Oncol (2003) 4.56
Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta (1991) 4.16
The emerging nanomedicine landscape. Nat Biotechnol (2006) 3.60
Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Clin Cancer Res (2001) 3.48
A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model. Cancer Res (2000) 2.99
Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol (2010) 2.66
Design of liposomes for enhanced local release of drugs by hyperthermia. Science (1978) 2.17
Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Cancer Res (2000) 2.17
Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times. Biochim Biophys Acta (1991) 2.08
Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects. J Natl Cancer Inst (2007) 2.03
The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors. Adv Drug Deliv Rev (2001) 2.01
Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors. Clin Cancer Res (2005) 1.81
Drug entrapment in liposomes. FEBS Lett (1973) 1.73
MRI monitoring of intratumoral drug delivery and prediction of the therapeutic effect with a multifunctional thermosensitive liposome. Biomaterials (2011) 1.71
Improved intratumoral nanoparticle extravasation and penetration by mild hyperthermia. J Control Release (2013) 1.66
In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: effects of PEG chain length and PC incorporation. J Pharm Sci (2004) 1.63
A novel two-step mild hyperthermia for advanced liposomal chemotherapy. J Control Release (2013) 1.58
Repulsive interactions and mechanical stability of polymer-grafted lipid membranes. Biochim Biophys Acta (1992) 1.58
Molecular mechanism of the lipid vesicle longevity in vivo. Biochim Biophys Acta (1993) 1.53
Image-guided drug delivery with magnetic resonance guided high intensity focused ultrasound and temperature sensitive liposomes in a rabbit Vx2 tumor model. J Control Release (2011) 1.49
Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors. Cancer Res (2012) 1.38
Phase I trial of doxorubicin-containing low temperature sensitive liposomes in spontaneous canine tumors. Clin Cancer Res (2006) 1.37
Lysolipid incorporation in dipalmitoylphosphatidylcholine bilayer membranes enhances the ion permeability and drug release rates at the membrane phase transition. Biochim Biophys Acta (2005) 1.36
Tumor-targeted nanomedicines: enhanced antitumor efficacy in vivo of doxorubicin-loaded, long-circulating liposomes modified with cancer-specific monoclonal antibody. Clin Cancer Res (2009) 1.35
Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks. Int J Radiat Oncol Biol Phys (1996) 1.32
Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery. Cancer Res (1982) 1.32
Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: an in vivo proof-of-concept study. J Control Release (2010) 1.32
Hyperthermia-triggered drug delivery from temperature-sensitive liposomes using MRI-guided high intensity focused ultrasound. J Control Release (2012) 1.27
Drug-carrier potential of liposomes in cancer chemotherapy. Lancet (1974) 1.24
In vivo monitoring of tissue pharmacokinetics of liposome/drug using MRI: illustration of targeted delivery. Magn Reson Med (2004) 1.20
Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia. J Control Release (2010) 1.19
Formulation and characterisation of magnetic resonance imageable thermally sensitive liposomes for use with magnetic resonance-guided high intensity focused ultrasound. Int J Hyperthermia (2011) 1.17
Novel temperature-sensitive liposomes with prolonged circulation time. Clin Cancer Res (2004) 1.15
Temperature-controlled structure and kinetics of ripple phases in one- and two-component supported lipid bilayers. Biophys J (2003) 1.14
Nanoscale Drug Delivery and Hyperthermia: The Materials Design and Preclinical and Clinical Testing of Low Temperature-Sensitive Liposomes Used in Combination with Mild Hyperthermia in the Treatment of Local Cancer. Open Nanomed J (2011) 1.14
Localised drug release using MRI-controlled focused ultrasound hyperthermia. Int J Hyperthermia (2010) 1.14
Liposome technology for industrial purposes. J Drug Deliv (2010) 1.14
Chemodosimetry of in vivo tumor liposomal drug concentration using MRI. Magn Reson Med (2006) 1.08
Comparative effects of thermosensitive doxorubicin-containing liposomes and hyperthermia in human and murine tumours. Int J Hyperthermia (2010) 1.08
Paramagnetic liposomes as MRI contrast agents: influence of liposomal physicochemical properties on the in vitro relaxivity. Magn Reson Imaging (1999) 1.06
Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy. J Control Release (2013) 1.05
Synthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome. J Control Release (2010) 1.04
Efficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicin. J Control Release (2011) 1.03
Temperature-sensitive liposomes for doxorubicin delivery under MRI guidance. J Control Release (2009) 1.02
The functional roles of poly(ethylene glycol)-lipid and lysolipid in the drug retention and release from lysolipid-containing thermosensitive liposomes in vitro and in vivo. J Pharm Sci (2010) 1.02
Phase I study of heat-deployed liposomal doxorubicin during radiofrequency ablation for hepatic malignancies. J Vasc Interv Radiol (2011) 1.02
In vitro stability and content release properties of phosphatidylglyceroglycerol containing thermosensitive liposomes. Biochim Biophys Acta (2007) 1.01
Tumour hyperthermia and ablation in rats using a clinical MR-HIFU system equipped with a dedicated small animal set-up. Int J Hyperthermia (2012) 1.01
Thermosensitive sterically stabilized liposomes: formulation and in vitro studies on mechanism of doxorubicin release by bovine serum and human plasma. Pharm Res (1995) 1.00
Thermosensitive liposomes for localized delivery and triggered release of chemotherapy. J Control Release (2013) 0.98
Novel temperature-triggered liposome with high stability: formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU). J Control Release (2013) 0.97
Heat-activated liposomal MR contrast agent: initial in vivo results in rabbit liver and kidney. Radiology (2004) 0.97
Noninvasive magnetic resonance thermography of recurrent rectal carcinoma in a 1.5 Tesla hybrid system. Cancer Res (2005) 0.95
Simultaneous T1 measurements and proton resonance frequency shift based thermometry using variable flip angles. Magn Reson Med (2011) 0.93
Optimization of a novel and improved thermosensitive liposome formulated with DPPC and a Brij surfactant using a robust in vitro system. J Control Release (2011) 0.92
Thermosensitive paramagnetic liposomes for temperature control during MR imaging-guided hyperthermia: in vitro feasibility studies. Acad Radiol (2000) 0.90
Tumor microvascular permeability is a key determinant for antivascular effects of doxorubicin encapsulated in a temperature sensitive liposome. Int J Hyperthermia (2008) 0.90
Targeted thermosensitive liposomes: an attractive novel approach for increased drug delivery to solid tumors. Expert Opin Drug Deliv (2013) 0.90
Stability and trapping of magnetic resonance imaging contrast agents during high-intensity focused ultrasound ablation therapy. Invest Radiol (2013) 0.89
Magnetic resonance guided high-intensity focused ultrasound mediated hyperthermia improves the intratumoral distribution of temperature-sensitive liposomal doxorubicin. Invest Radiol (2013) 0.89
Targeting anticancer drugs to tumor vasculature using cationic liposomes. Pharm Res (2010) 0.89
Paramagnetic liposomes for molecular MRI and MRI-guided drug delivery. NMR Biomed (2013) 0.88
Modulation of doxorubicin resistance in multidrug-resistance cells by targeted liposomes combined with hyperthermia. J Biochem Mol Biol Biophys (2002) 0.88
Hyperthermia-induced drug targeting. Expert Opin Drug Deliv (2013) 0.88
Enhanced delivery of doxorubicin to tumor by long-circulating thermosensitive liposomes and local hyperthermia. Biochim Biophys Acta (1993) 0.87
Disc formation in cholesterol-free liposomes during phase transition. Biochim Biophys Acta (2003) 0.87
MR characterization of mild hyperthermia-induced gadodiamide release from thermosensitive liposomes in solid tumors. Invest Radiol (2008) 0.87
Encapsulation of doxorubicin into thermosensitive liposomes via complexation with the transition metal manganese. J Control Release (2005) 0.87
Paramagnetic thermosensitive liposomes for MR-thermometry. Int J Hyperthermia (2005) 0.86
Cationic thermosensitive liposomes: a novel dual targeted heat-triggered drug delivery approach for endothelial and tumor cells. Nano Lett (2012) 0.86
Use of a passive equilibration methodology to encapsulate cisplatin into preformed thermosensitive liposomes. Int J Pharm (2007) 0.85
Dual role of hexadecylphosphocholine (miltefosine) in thermosensitive liposomes: active ingredient and mediator of drug release. J Control Release (2007) 0.85
SPECT/CT imaging of temperature-sensitive liposomes for MR-image guided drug delivery with high intensity focused ultrasound. J Control Release (2013) 0.85
Size of thermosensitive liposomes influences content release. J Control Release (2010) 0.85
A two-component drug delivery system using Her-2-targeting thermosensitive liposomes. J Drug Target (2009) 0.84
Questions on the role of the EPR effect in tumor targeting. J Control Release (2013) 0.82
A thermosensitive liposome prepared with a Cu²⁺ gradient demonstrates improved pharmacokinetics, drug delivery and antitumor efficacy. J Control Release (2012) 0.82
Thermosensitive liposomes for the delivery of gemcitabine and oxaliplatin to tumors. Mol Pharm (2013) 0.82
Intact Doxil is taken up intracellularly and released doxorubicin sequesters in the lysosome: evaluated by in vitro/in vivo live cell imaging. J Control Release (2013) 0.82
Model of interfacial melting. Phys Rev Lett (1987) 0.81
Liposomes designed to avoid the reticuloendothelial system. Prog Clin Biol Res (1990) 0.81
Effect of lanthanum ions on the phase transitions of lecithin bilayers. Biophys J (1984) 0.81
In vitro characterization of phosphatidylglyceroglycerol-based thermosensitive liposomes with encapsulated 1H MR T1-shortening gadodiamide. Contrast Media Mol Imaging (2008) 0.79
Proteins and cholesterol lipid vesicles are mediators of drug release from thermosensitive liposomes. J Control Release (2012) 0.78
Gemcitabine treatment of rat soft tissue sarcoma with phosphatidyldiglycerol-based thermosensitive liposomes. Pharm Res (2014) 0.78
Use of temperature-sensitive liposomes in the selective delivery of methotrexate and cis-platinum analogues to murine bladder tumor. J Urol (1986) 0.77
Triggered release of doxorubicin from temperature-sensitive poly(N-(2-hydroxypropyl)-methacrylamide mono/dilactate) grafted liposomes. Biomacromolecules (2014) 0.77
[MRI-controlled regional hyperthermia]. Radiologe (1999) 0.76
Non-ionic Gd-based MRI contrast agents are optimal for encapsulation into phosphatidyldiglycerol-based thermosensitive liposomes. J Control Release (2012) 0.76